GEN Exclusives

More »

GEN News Highlights

More »
Mar 6, 2009

UCB Taps Proteros for Structure-Based Drug Discovery

  • UCB is employing Proteros biostructures to support structure-based discovery of small molecule drugs. Proteos will receive research fees and milestones.

    Initially, Proteros will leverage its expertise in gene-to-structure projects and its technologies to solve the 3-D structure of an undisclosed target together with its related proteins.

    After the establishment of these crystallography systems, Proteros will screen fragments and compounds supplied by UCB with the objective of confirming the binding modes to the proteins. This will facilitate medicinal chemistry research and optimization of small molecules, the companies say.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Companion Animal Care

Do you think Americans spend too much on companion animal care?